Skip to main content

Advertisement

SpringerLink
Log in

Clinical characteristics, morbidity, and prognostic value of concomitant coronary artery disease in idiopathic dilated cardiomyopathy

  • Original Paper
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

Abstract

Background

Patients with idiopathic dilated cardiomyopathy (dCMP) might present coronary artery disease (CAD) concomitant to dCMP and prognostic differences between ischemic heart disease and non-ischemic cardiomyopathy have been described. Clinical characteristics and prognostic implications of concomitant CAD in patients with dCMP are largely unknown.

Methods

A total of 1,263 patients with chronic systolic dysfunction from dCMP—of these 67.1 % (n = 847; 72.3 % men) without and 32.9 % (n = 416; 80.8 % men) with concomitant CAD were included and baseline clinical characteristics noted. They were followed prospectively for 36.3 (20.8–65.0) months, representing 5,168 patient-years. All-cause mortality was the primary endpoint; and decompensation requiring hospitalisation as well as the combined endpoint thereof were secondary endpoints.

Results

Independent significant predictors of CAD were smoking status (current smoker: OR 2.68, 95 % CI 1.61–4.46; p < 0.001; past smoker: OR 2.52, 95 % CI 1.40–4.52; p < 0.005; each vs. non-smoker), presence of dyslipidemia (OR 3.46, 95 % CI 2.23–5.35; p < 0.001), age (OR 1.06, 95 % CI 1.04–1.08; p < 0.001), and female sex (OR 0.49, 95 % CI 0.29–0.81; p = 0.005). The presence of CAD was not a significant predictor of all-cause mortality (adjusted HR 0.74, 95 % CI 0.36–1.54; p = 0.42), morbidity (adjusted HR 1.48, 95 % CI 0.55–3.99; p = 0.44), or the combined endpoint (HR 0.65, 95 % CI 0.24–1.78; p = 0.40).

Conclusion

Concomitant CAD is common in patients with dCMP. Clinical predictors of its presence are largely coincident with classic risk factors in the general population. The presence of concomitant CAD appears not to be associated with adverse prognosis (morbidity or mortality) in patients with dCMP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kuhl U, Maisch B, McKenna WJ, Monserrat L, Pankuweit S, Rapezzi C, Seferovic P, Tavazzi L, Keren A (2008) Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 29:270–276

    Article  PubMed  Google Scholar 

  2. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB (2006) Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113:1807–1816

    Article  PubMed  Google Scholar 

  3. Esser S, Gelbrich G, Brockmeyer N, Goehler A, Schadendorf D, Erbel R, Neumann T, Reinsch N (2013) Prevalence of cardiovascular diseases in HIV-infected outpatients: results from a prospective, multicenter cohort study. Clin Res Cardiol 102:203–213

    Article  PubMed  Google Scholar 

  4. Angelini A, Boffa GM, Livi U, Barchitta A, Casarotto D, Thiene G (1999) Discordance between pre and post cardiac transplant diagnosis: implications for pre- and postoperative decision making. Cardiovasc Pathol 8:17–23

    Article  PubMed  CAS  Google Scholar 

  5. Bortman G, Sellanes M, Odell DS, Ring WS, Olivari MT (1994) Discrepancy between pre- and post-transplant diagnosis of end-stage dilated cardiomyopathy. Am J Cardiol 74:921–924

    Article  PubMed  CAS  Google Scholar 

  6. Repetto A, Dal Bello B, Pasotti M, Agozzino M, Vigano M, Klersy C, Tavazzi L, Arbustini E (2005) Coronary atherosclerosis in end-stage idiopathic dilated cardiomyopathy: an innocent bystander? Eur Heart J 26:1519–1527

    Article  PubMed  Google Scholar 

  7. Waller TA, Hiser WL, Capehart JE, Roberts WC (1998) Comparison of clinical and morphologic cardiac findings in patients having cardiac transplantation for ischemic cardiomyopathy, idiopathic dilated cardiomyopathy, and dilated hypertrophic cardiomyopathy. Am J Cardiol 81:884–894

    Article  PubMed  CAS  Google Scholar 

  8. McCrohon JA, Moon JC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJ, Pennell DJ (2003) Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 108:54–59

    Article  PubMed  CAS  Google Scholar 

  9. Hedrich O, Jacob M, Hauptman PJ (2004) Progression of coronary artery disease in non-ischemic dilated cardiomyopathy. Coron Artery Dis 15:291–297

    Article  PubMed  Google Scholar 

  10. White BM, Mehta R, Binkley PF, Leier CV (2009) Latent development of occlusive coronary atherosclerosis as a cause of decompensation of non-ischemic dilated cardiomyopathy. Cardiology 112:69–73

    Article  PubMed  CAS  Google Scholar 

  11. Adams KF Jr, Dunlap SH, Sueta CA, Clarke SW, Patterson JH, Blauwet MB, Jensen LR, Tomasko L, Koch G (1996) Relation between gender, etiology and survival in patients with symptomatic heart failure. J Am Coll Cardiol 28:1781–1788

    Article  PubMed  Google Scholar 

  12. Ghali JK, Krause-Steinrauf HJ, Adams KF, Khan SS, Rosenberg YD, Yancy CW, Young JB, Goldman S, Peberdy MA, Lindenfeld J (2003) Gender differences in advanced heart failure: insights from the BEST study. J Am Coll Cardiol 42:2128–2134

    Article  PubMed  Google Scholar 

  13. Bart BA, Shaw LK, McCants CB Jr, Fortin DF, Lee KL, Califf RM, O’Connor CM (1997) Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol 30:1002–1008

    Article  PubMed  CAS  Google Scholar 

  14. Felker GM, Shaw LK, O’Connor CM (2002) A standardized definition of ischemic cardiomyopathy for use in clinical research. J Am Coll Cardiol 39:210–218

    Article  PubMed  Google Scholar 

  15. Ndrepepa G, Tada T, Fusaro M, Cassese S, King L, Hadamitzky M, Haase HU, Schomig A, Kastrati A, Pache J (2012) Association of coronary atherosclerotic burden with clinical presentation and prognosis in patients with stable and unstable coronary artery disease. Clin Res Cardiol 101:1003–1011

    Article  PubMed  Google Scholar 

  16. Remme WJ, Swedberg K (2002) Comprehensive guidelines for the diagnosis and treatment of chronic heart failure. Task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Eur J Heart Fail 4:11–22

    Article  PubMed  Google Scholar 

  17. Authors/Task Force M, McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Guidelines ESCCfP, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, Document R, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 14:803–869

  18. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K, Vahanian A, Camm J, De Caterina R, Dean V, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29:2388–2442

    Article  PubMed  CAS  Google Scholar 

  19. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW (2009) 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119:e391–e479

    Article  PubMed  Google Scholar 

  20. Wynne J, Braunwald E (2001) The cardiomyopathies and myocarditides. In: Braunwald E, Zipes DP, Libby P (eds) Heart disease. Saunders, Philadelphia, pp 1751–1806

    Google Scholar 

  21. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461–470

    Article  PubMed  CAS  Google Scholar 

  22. Lin D, Wei L, Ying Z (1993) Checking the Cox model with cumulative sums of martingale-based residuals. Biometrika 80:557–572

    Article  Google Scholar 

  23. Therneau TM, Grambsch PM, Fleming TR (1990) Martingale-based residuals for survival models. Biometrika 77:147–160

    Article  Google Scholar 

  24. LTD STP Sample Size for Survival Rates Program. In: Chang A (ed) StatsToDo

  25. Cleland JG, Thygesen K, Uretsky BF, Armstrong P, Horowitz JD, Massie B, Packer M, Poole-Wilson PA, Ryden L (2001) Cardiovascular critical event pathways for the progression of heart failure; a report from the ATLAS study. Eur Heart J 22:1601–1612

    Article  PubMed  CAS  Google Scholar 

  26. Yusuf S, Pepine CJ, Garces C, Pouleur H, Salem D, Kostis J, Benedict C, Rousseau M, Bourassa M, Pitt B (1992) Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet 340:1173–1178

    Article  PubMed  CAS  Google Scholar 

  27. Cooke GE, Eaton GM, Whitby G, Kennedy RA, Binkley PF, Moeschberger ML, Leier CV (2000) Plasma atherogenic markers in congestive heart failure and posttransplant (heart) patients. J Am Coll Cardiol 36:509–516

    Article  PubMed  CAS  Google Scholar 

  28. Franciosa JA, Wilen M, Ziesche S, Cohn JN (1983) Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol 51:831–836

    Article  PubMed  CAS  Google Scholar 

  29. Kelly TL, Cremo R, Nielsen C, Shabetai R (1990) Prediction of outcome in late-stage cardiomyopathy. Am Heart J 119:1111–1121

    Article  PubMed  CAS  Google Scholar 

  30. Pereira VF, de Carvalho Frimm C, Rodrigues AC, Curi M (2010) Coronary reserve impairment prevents the improvement of left ventricular dysfunction and adversely affects the long-term outcome of patients with hypertensive dilated cardiomyopathy. J Am Soc Hypertens 4:14–21

    Article  PubMed  Google Scholar 

  31. de Jong RM, Tio RA, van der Harst P, Voors AA, Koning PM, Zeebregts CJ, van Veldhuisen DJ, Dierckx RA, Slart RH (2009) Ischemic patterns assessed by positron emission tomography predict adverse outcome in patients with idiopathic dilated cardiomyopathy. J Nucl Cardiol 16:769–774

    Article  PubMed  Google Scholar 

  32. de Groote P, Lamblin N, Mouquet F, Bauters C (2008) No gender survival difference in a population of patients with chronic heart failure related to left ventricular systolic dysfunction and receiving optimal medical therapy. Arch Cardiovasc Dis 101:242–248

    Article  PubMed  Google Scholar 

  33. Frankenstein L, Remppis A, Fluegel A, Doesch A, Katus HA, Senges J, Zugck C (2010) The association between long-term longitudinal trends in guideline adherence and mortality in relation to age and sex. Eur J Heart Fail 12:574–580

    Article  PubMed  Google Scholar 

  34. Lupon J, Urrutia A, Gonzalez B, Diez C, Altimir S, Albaladejo C, Pascual T, Rey-Joly C, Valle V (2007) Does heart failure therapy differ according to patient sex? Clin Cardiol 30:301–305

    Article  PubMed  Google Scholar 

  35. Franke J, Zugck C, Wolter JS, Frankenstein L, Hochadel M, Ehlermann P, Winkler R, Nelles M, Zahn R, Katus HA, Senges J (2012) A decade of developments in chronic heart failure treatment: a comparison of therapy and outcome in a secondary and tertiary hospital setting. Clin Res Cardiol 101:1–10

    Article  PubMed  Google Scholar 

  36. Rihal CS, Raco DL, Gersh BJ, Yusuf S (2003) Indications for coronary artery bypass surgery and percutaneous coronary intervention in chronic stable angina: review of the evidence and methodological considerations. Circulation 108:2439–2445

    Article  PubMed  Google Scholar 

  37. Weintraub WS, Spertus JA, Kolm P, Maron DJ, Zhang Z, Jurkovitz C, Zhang W, Hartigan PM, Lewis C, Veledar E, Bowen J, Dunbar SB, Deaton C, Kaufman S, O’Rourke RA, Goeree R, Barnett PG, Teo KK, Boden WE, Group CTR, Mancini GB (2008) Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med 359:677–687

    Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Cardiology, Angiology, Pulmonology, University of Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany

    Lutz Frankenstein, Henrik Hees, Tobias Taeger, Hanna Froehlich, Andreas Dösch, Rita Cebola, Christian Zugck & Hugo A. Katus

Authors
  1. Lutz Frankenstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Henrik Hees
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tobias Taeger
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hanna Froehlich
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Andreas Dösch
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Rita Cebola
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Christian Zugck
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hugo A. Katus
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lutz Frankenstein.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Frankenstein, L., Hees, H., Taeger, T. et al. Clinical characteristics, morbidity, and prognostic value of concomitant coronary artery disease in idiopathic dilated cardiomyopathy. Clin Res Cardiol 102, 771–780 (2013). https://doi.org/10.1007/s00392-013-0589-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-013-0589-7

Keywords

Search

Navigation